| abstract |
A pharmaceutical form for thyroid hormone and a method for obtaining the pharmaceutical form, which enable safe and constant oral administration. A thyroid hormone, preferably T3 and / or T4 or a salt thereof, in a homogeneous matrix of a soft gel which can be ingested without biting, is administered at a pharmaceutically effective concentration, preferably 0.001. Pharmaceutical composition containing 〜1% by weight. In that composition, the homogeneous matrix has the shape and dimensions of a tablet or capsule. Said composition is composed of 30% to 68% by weight of gelatin, in a dry state, of bovine, porcine or fish origin. The composition is characterized in that it contains 31% to 60% by weight of glycerol and 1% to 10% by weight of water in a dry state. [Selection diagram] None |